In February a study was published out of France that the very old malaria drug, hydroxychloroquine (HCQ), could inhibit the infection of cell cultures in the laboratory with the SARS-CoV-2 virus. I did an analysis of the data within 24 hours and posted a note on social media that the concentration needed for it to work in the test tube was not reached by the drug when given in normal doses. I was skeptical of it working.